FDA Urges HCPs to Follow Authorized Dosing Schedules for COVID-19 Vaccines
Additional research from the vaccine manufacturers would be needed to support any changes to the dosing schedule.
Vaccines
Moderna Increases Production Estimates of COVID-19 Vaccine for 2021
Moderna is increasing its baseline production estimates for its COVID-19 vaccine from 500 to 600 million doses for 2021.
Phase 3 Trial of Novavax’s COVID-19 Vaccine Begins
The vaccine candidate contains the Company’s saponin-based Matrix-M™ adjuvant technology to enhance and prolong immune responses.
Methotrexate Discontinuation May Improve Influenza Vaccine Response During the COVID-19 Pandemic
Study authors evaluated the effects of methotrexate discontinuation on influenza vaccine response during the COVID-19 pandemic.
Moderna’s COVID-19 Vaccine Gets EUA; Shipping Begins
The FDA has granted an EUA to Moderna’s COVID-19 vaccine, mRNA-1237, for active immunization.
AstraZeneca Vaccine Candidate Effective Against COVID-19
A total of 131 cases of COVID-19 were reported in the interim analysis, with no hospitalizations or severe cases noted in participants who received the vaccine.
Pfizer COVID-19 Vaccine Reaches 90% Effectiveness in Early Analysis
A new vaccine developed by Pfizer and the German biotechnology firm BioNTech was more than 90% effective at protecting people from COVID-19.
Interim Data Show COVID-19 Vaccine Candidate mRNA-1273 Nearly 95% Effective
A phase 3 trial evaluating the vaccine candidate mRNA-1273 against COVID-19 met its primary efficacy end point in the first interim analysis.
COVID-19 Vaccine Allocation: Ethical Concerns, Practical Challenges
In the event of a likely scarcity of COVID-19 vaccines, a framework must be developed to inform who should get priority.
Inactivated SARS-CoV-2 Vaccine Well Tolerated in Phase 1/2 Trial
An inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine seems safe and induces humoral responses.
-
Loading...
-
Loading...
Next post in General Rheumatology
